1991
DOI: 10.1016/0014-2999(91)90045-r
|View full text |Cite
|
Sign up to set email alerts
|

Effects of pharmacological manipulation of GABAergic neurotransmission in a new mutant hamster model of paroxysmal dystonia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
22
1

Year Published

1995
1995
2005
2005

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 71 publications
(23 citation statements)
references
References 14 publications
0
22
1
Order By: Relevance
“…The dt sz hamsters were obtained by selective breeding as described in detail elsewhere (Fredow and Löscher, 1991). The control hamsters were obtained from breeding pairs which were provided by a commercial breeder (Central Institute for Laboratory Animal Breeding, Hannover, Germany).…”
Section: Materials and Methods Animalsmentioning
confidence: 99%
See 2 more Smart Citations
“…The dt sz hamsters were obtained by selective breeding as described in detail elsewhere (Fredow and Löscher, 1991). The control hamsters were obtained from breeding pairs which were provided by a commercial breeder (Central Institute for Laboratory Animal Breeding, Hannover, Germany).…”
Section: Materials and Methods Animalsmentioning
confidence: 99%
“…Recent pharmacological and neurochemical studies in the dt sz hamster have indicated that an impaired GABAergic function is critically involved in the pathophysiology of generalized dystonia (Fredow and Löscher, 1991;Löscher and Hörstermann, 1992;Nobrega et al, 1995;Pratt et al, 1995;Richter and Löscher, 1993). GABA-potentiating drugs were shown to exert antidystonic effects, while the central stimulant pentylenetetrazole (PTZ), which is thought to reduce GABA A receptor function by an effect on the picrotoxinin site of the GABA A receptor complex (Löscher, 1989;Ramanjaneyulu and Ticku, 1984), aggravated dystonia in mutant hamsters at subconvulsive doses (Fredow and Löscher, 1991;Löscher et al, 1989).…”
Section: Introductionmentioning
confidence: 98%
See 1 more Smart Citation
“…Systemic administration or intrastriatal injection of agents that increase GABAergic transmission either ameliorate or block dt sz attacks. 10,16,17 In contrast, systemic or local application of GABA receptor antagonists worsens the dystonia. 10,16,17 The improvement observed with drugs that promote GABA release likely occurs by offsetting the significant deficit of GABAergic striatal interneurons, which predicts disinhibition of striatal efferents.…”
Section: Animal Models Implicating Basal Ganglia Dysfunctionmentioning
confidence: 99%
“…10,16,17 In contrast, systemic or local application of GABA receptor antagonists worsens the dystonia. 10,16,17 The improvement observed with drugs that promote GABA release likely occurs by offsetting the significant deficit of GABAergic striatal interneurons, which predicts disinhibition of striatal efferents. 15 These defects in GABAergic regulation within the striatum suggest the dt sz disorder may be pathogenically related to some forms of idiopathic paroxysmal dyskinesia in humans because dystonia in mutant hamsters and patients responds to similar pharmacological treatments, such as systemic administration of benzodiazepines.…”
Section: Animal Models Implicating Basal Ganglia Dysfunctionmentioning
confidence: 99%